1. GPCR/G Protein Neuronal Signaling
  2. Dopamine Receptor
  3. (S)-Remoxipride

(S)-Remoxipride  (Synonyms: (-)-Remoxipride)

Cat. No.: HY-101313
Handling Instructions

(S)-Remoxipride ((-)-Remoxipride) is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride can be used for the research of psychotic disorder.

For research use only. We do not sell to patients.

(S)-Remoxipride Chemical Structure

(S)-Remoxipride Chemical Structure

CAS No. : 80125-14-0

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of (S)-Remoxipride:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

(S)-Remoxipride ((-)-Remoxipride) is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride can be used for the research of psychotic disorder[1].

IC50 & Target

D2 Receptor

1.57 μM (IC50)

D1 Receptor

>100 μM (IC50)

α1-Adrenoccptor

42 μM (IC50)

In Vitro

(S)-Remoxipride (1-100 μM; 20 min) shows binding efficiency with IC50s of >100, 1.57 and 42 μM for dopamine D1, dopamine D2 and α1-Adrenoccptor, respectively[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

(S)-Remoxipride (0.1-100 μM/kg; i.p. 60 min prior to apomorphine) blockades apomorphine-induced behaviors s in rats and vomiting in dogs[1].
(S)-Remoxipride (0.1-10 mg/kg; i.p. 30 min prior to apomorphine) displaces [3H]spiperone from both striatal and extra-striatal areas[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague-Dawley rats[1]
Dosage: 0.1-100 μM/kg
Administration: Intraperitoneal injection; 0.1-100 μM/kg; 60 min prior to apomorphine
Result: Blocked apomorphine-induced hyperactivity and dose-dependent blockaded apomorphine-induced behaviors in vivo.
Animal Model: Male and female beagle dogs[1]
Dosage: 0.25-5 μM/kg
Administration: Oral gavage; 0.25-5 μM/kg; 60 min prior to apomorphine
Result: Blocked apomorphine-induced vomiting in dogs.
Molecular Weight

371.27

Formula

C16H23BrN2O3

CAS No.
SMILES

O=C(NC[C@H]1N(CC)CCC1)C2=C(OC)C=CC(Br)=C2OC

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
(S)-Remoxipride
Cat. No.:
HY-101313
Quantity:
MCE Japan Authorized Agent: